Loading...
Pioglitazone improves whole‐body aerobic capacity and skeletal muscle energy metabolism in patients with metabolic syndrome
AIMS/INTRODUCTION: Low aerobic capacity is a strong and independent predictor of all‐cause mortality in patients with metabolic syndrome (MetS). Here, we investigated the effects of pioglitazone treatment on whole‐body aerobic capacity and skeletal muscle energy metabolism in MetS patients. MATERIAL...
Na minha lista:
| Udgivet i: | J Diabetes Investig |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5497029/ https://ncbi.nlm.nih.gov/pubmed/27930876 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12606 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|